Pharmaceutical composition comprising GLP-1 agonist, insulin, and methionine
The invention relates to a pharmaceutical composition comprising a GLP-1 agonist, an insulin, and a methionine, and specifically to a liquid composition comprising a GLP-1 agonist or/and a pharmacologically tolerable salt thereof, an insulin or/and a pharmacologically tolerable salt thereof, and opt...
Gespeichert in:
| Hauptverfasser: | , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | chi ; eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | MUELLER WERNER TERTSCH KATRIN SIEFKE-HENZLER VERENA HAGENDORF ANNIKA SCHOETTLE ISABELL HAUCK GERRIT |
| description | The invention relates to a pharmaceutical composition comprising a GLP-1 agonist, an insulin, and a methionine, and specifically to a liquid composition comprising a GLP-1 agonist or/and a pharmacologically tolerable salt thereof, an insulin or/and a pharmacologically tolerable salt thereof, and optionally at least one pharmaceutically acceptable adjuvant, the composition being characterised in that it contains methionine, optionally as add-on therapy with metformin.
本发明涉及种包含GLP-1激动剂、胰岛素和甲硫氨酸的药物组合物。具体而言涉及种液体组合物，其包含GLP-1激动剂或/和其药理学可容许盐、胰岛素或/和其药理学可容许盐、和任选地至少种药学可接受赋形剂，其中所述组合物包含甲硫氨酸，在适当情况中作为用二甲双胍的添加疗法。 |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_CN107308442A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CN107308442A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_CN107308442A3</originalsourceid><addsrcrecordid>eNrjZPAJyEgsyk1MTi0tyUxOzFFIzs8tyC_OLMnMzwOzizKLM_PSFdx9AnQNFRLT8_Myi0t0FDLziktzMvN0FBLzUhRyU0sygMoz81J5GFjTEnOKU3mhNDeDoptriLOHbmpBfnxqcQHQmrzUknhnP0MDc2MDCxMTI0djYtQAAJIcNZI</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Pharmaceutical composition comprising GLP-1 agonist, insulin, and methionine</title><source>esp@cenet</source><creator>MUELLER WERNER ; TERTSCH KATRIN ; SIEFKE-HENZLER VERENA ; HAGENDORF ANNIKA ; SCHOETTLE ISABELL ; HAUCK GERRIT</creator><creatorcontrib>MUELLER WERNER ; TERTSCH KATRIN ; SIEFKE-HENZLER VERENA ; HAGENDORF ANNIKA ; SCHOETTLE ISABELL ; HAUCK GERRIT</creatorcontrib><description>The invention relates to a pharmaceutical composition comprising a GLP-1 agonist, an insulin, and a methionine, and specifically to a liquid composition comprising a GLP-1 agonist or/and a pharmacologically tolerable salt thereof, an insulin or/and a pharmacologically tolerable salt thereof, and optionally at least one pharmaceutically acceptable adjuvant, the composition being characterised in that it contains methionine, optionally as add-on therapy with metformin.
本发明涉及种包含GLP-1激动剂、胰岛素和甲硫氨酸的药物组合物。具体而言涉及种液体组合物，其包含GLP-1激动剂或/和其药理学可容许盐、胰岛素或/和其药理学可容许盐、和任选地至少种药学可接受赋形剂，其中所述组合物包含甲硫氨酸，在适当情况中作为用二甲双胍的添加疗法。</description><language>chi ; eng</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2017</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20171103&DB=EPODOC&CC=CN&NR=107308442A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20171103&DB=EPODOC&CC=CN&NR=107308442A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>MUELLER WERNER</creatorcontrib><creatorcontrib>TERTSCH KATRIN</creatorcontrib><creatorcontrib>SIEFKE-HENZLER VERENA</creatorcontrib><creatorcontrib>HAGENDORF ANNIKA</creatorcontrib><creatorcontrib>SCHOETTLE ISABELL</creatorcontrib><creatorcontrib>HAUCK GERRIT</creatorcontrib><title>Pharmaceutical composition comprising GLP-1 agonist, insulin, and methionine</title><description>The invention relates to a pharmaceutical composition comprising a GLP-1 agonist, an insulin, and a methionine, and specifically to a liquid composition comprising a GLP-1 agonist or/and a pharmacologically tolerable salt thereof, an insulin or/and a pharmacologically tolerable salt thereof, and optionally at least one pharmaceutically acceptable adjuvant, the composition being characterised in that it contains methionine, optionally as add-on therapy with metformin.
本发明涉及种包含GLP-1激动剂、胰岛素和甲硫氨酸的药物组合物。具体而言涉及种液体组合物，其包含GLP-1激动剂或/和其药理学可容许盐、胰岛素或/和其药理学可容许盐、和任选地至少种药学可接受赋形剂，其中所述组合物包含甲硫氨酸，在适当情况中作为用二甲双胍的添加疗法。</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2017</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZPAJyEgsyk1MTi0tyUxOzFFIzs8tyC_OLMnMzwOzizKLM_PSFdx9AnQNFRLT8_Myi0t0FDLziktzMvN0FBLzUhRyU0sygMoz81J5GFjTEnOKU3mhNDeDoptriLOHbmpBfnxqcQHQmrzUknhnP0MDc2MDCxMTI0djYtQAAJIcNZI</recordid><startdate>20171103</startdate><enddate>20171103</enddate><creator>MUELLER WERNER</creator><creator>TERTSCH KATRIN</creator><creator>SIEFKE-HENZLER VERENA</creator><creator>HAGENDORF ANNIKA</creator><creator>SCHOETTLE ISABELL</creator><creator>HAUCK GERRIT</creator><scope>EVB</scope></search><sort><creationdate>20171103</creationdate><title>Pharmaceutical composition comprising GLP-1 agonist, insulin, and methionine</title><author>MUELLER WERNER ; TERTSCH KATRIN ; SIEFKE-HENZLER VERENA ; HAGENDORF ANNIKA ; SCHOETTLE ISABELL ; HAUCK GERRIT</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_CN107308442A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>chi ; eng</language><creationdate>2017</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>MUELLER WERNER</creatorcontrib><creatorcontrib>TERTSCH KATRIN</creatorcontrib><creatorcontrib>SIEFKE-HENZLER VERENA</creatorcontrib><creatorcontrib>HAGENDORF ANNIKA</creatorcontrib><creatorcontrib>SCHOETTLE ISABELL</creatorcontrib><creatorcontrib>HAUCK GERRIT</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>MUELLER WERNER</au><au>TERTSCH KATRIN</au><au>SIEFKE-HENZLER VERENA</au><au>HAGENDORF ANNIKA</au><au>SCHOETTLE ISABELL</au><au>HAUCK GERRIT</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Pharmaceutical composition comprising GLP-1 agonist, insulin, and methionine</title><date>2017-11-03</date><risdate>2017</risdate><abstract>The invention relates to a pharmaceutical composition comprising a GLP-1 agonist, an insulin, and a methionine, and specifically to a liquid composition comprising a GLP-1 agonist or/and a pharmacologically tolerable salt thereof, an insulin or/and a pharmacologically tolerable salt thereof, and optionally at least one pharmaceutically acceptable adjuvant, the composition being characterised in that it contains methionine, optionally as add-on therapy with metformin.
本发明涉及种包含GLP-1激动剂、胰岛素和甲硫氨酸的药物组合物。具体而言涉及种液体组合物，其包含GLP-1激动剂或/和其药理学可容许盐、胰岛素或/和其药理学可容许盐、和任选地至少种药学可接受赋形剂，其中所述组合物包含甲硫氨酸，在适当情况中作为用二甲双胍的添加疗法。</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | chi ; eng |
| recordid | cdi_epo_espacenet_CN107308442A |
| source | esp@cenet |
| subjects | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | Pharmaceutical composition comprising GLP-1 agonist, insulin, and methionine |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T08%3A28%3A38IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=MUELLER%20WERNER&rft.date=2017-11-03&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ECN107308442A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |